01/24/2012
https://congress.gov...
"We cannot rest on our laurels. We have an obligation to periodically reevaluate and adjust to account for the sweeping changes in the health sector."
"The foundation laid by Hatch-Waxman Act 30 years ago will continue to be the mechanism by which the management incentives development of lifesaving drugs but we do have an obligation to periodically r..."
"We cannot legislate scientific advances. In some areas, the lack of new treatments is attributable to a lack of scientific knowledge, not the lack of incentives."
"In a biosimilars provision in the Affordable Care Act, we gave 12 years of exclusivity to biologics."